Concord Wealth Partners Elanco Animal Health Inc Transaction History

Concord Wealth Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Apr 30, 2024	BUY	$9.81 - $12.62 $1,363 - $1,754	139 New	139 $1,000
Q4 2022 Jan 27, 2023	BUY	$11.49 - $13.65 $1,597 - $1,897	139 New	139 $1,000
Q3 2021 Nov 09, 2021	SELL	$29.2 - $36.72 $6,278 - $7,894	-215 Reduced 60.73%	139 $4,000
Q1 2021 May 13, 2021	BUY	$27.85 - $34.49 $9,858 - $12,209	354 New	354 $10,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.71B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.